← Back to Clinical Trials
Recruiting NCT07017062

NCT07017062 Clinical Evaluation of Hybrid Ceramic Occlusal Veneers Bonded With Two Self Adhesive Resin Cements

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07017062
Status Recruiting
Phase
Sponsor Cairo University
Condition Occlusal Wear of Teeth
Study Type INTERVENTIONAL
Enrollment 44 participants
Start Date 2025-06
Primary Completion 2025-07

Eligibility & Interventions

Sex All sexes
Min Age 21 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
hybrid ceramic occlusal veneers

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 44 participants in total. It began in 2025-06 with a primary completion date of 2025-07.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This randomized clinical trial aims to evaluate the clinical performance of hybrid ceramic occlusal veneers cemented with two different bonding protocols: a self-adhesive bonding protocol with adhesive enhancement (BeautiLink SA cement with BeautiBond Xtreme adhesive) versus another self-adhesive bonding protocol (RelyX U200 self-adhesive resin cement with 3M UNIVERSAL bond).

Eligibility Criteria

Inclusion Criteria: * • Age ≥ 21 years * Vital teeth * Sufficient tooth structure for veneer retention * Willing and able to provide written informed consent * Ability to attend all follow-up appointments * Adequate oral hygiene as determined by the investigator Exclusion Criteria: * • Patients with active periodontal disease (probing depth \> 4mm, bleeding on probing) * Patients with severe parafunctional habits (e.g., bruxism confirmed by clinical examination) * Poor oral hygiene (plaque index \> 30%) * Pregnancy or nursing * Systemic diseases affecting treatment outcomes (e.g., uncontrolled diabetes, immunosuppression) * Known allergies to study materials (ceramic, or resin cement components) * Inability to comply with study requirements * Current participation in other dental clinical trials * Active orthodontic treatment

Contact & Investigator

Central Contact

Hayat Ibrahim El Banna, Lecturer

✉ hayat.elbanna@dentistry.cu.edu.eg

📞 00201001248734

Frequently Asked Questions

Who can join the NCT07017062 clinical trial?

This trial is open to participants of all sexes, aged 21 Years or older, studying Occlusal Wear of Teeth. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07017062 currently recruiting?

Yes, NCT07017062 is actively recruiting participants. Contact the research team at hayat.elbanna@dentistry.cu.edu.eg for enrollment information.

Where is the NCT07017062 trial being conducted?

This trial is being conducted at Cairo, Egypt.

Who is sponsoring the NCT07017062 clinical trial?

NCT07017062 is sponsored by Cairo University. The trial plans to enroll 44 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology